Product Information
INVEGA SUSTENNA 156 MG/ML SYRG is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $2337.6322 per ML under NDC 50458056301. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jul 31, 2009.
Strength
156 mg/mL
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458056301
Classification
Brand
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
8/19/2026
Active Ingredients
PALIPERIDONE PALMITATEApproval Type
New Drug (NDA)
FDA Application
NDA022264FDA Approved
7/31/2009
On Market Since
7/31/2009
Pharmacological Classes
Price Statistics
The NADAC for INVEGA SUSTENNA 156 MG/ML SYRG has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 103.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2337.6322 per ML |
|---|---|
| All-time high | $2339.6450 (May 13, 2026) |
| All-time low | $1146.8243 (Nov 28, 2013) |
| 52-week high | $2339.6450 |
| 52-week low | $2282.8241 |
| Median price | $1797.6034 |
| Average price | $1775.0544 |
| Largest weekly change | +6.9% (Jan 16, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the paliperidone palmitate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INVEGA SUSTENNA 156 MG/ML SYRG?
The current National Average Drug Acquisition Cost (NADAC) for INVEGA SUSTENNA 156 MG/ML SYRG, manufactured by Janssen Pharmaceuticals Inc., is $2337.6322 per ML (NDC 50458056301), effective Aug 19, 2026.
How has the price of INVEGA SUSTENNA 156 MG/ML SYRG changed over time?
Over the history we have for it, the NADAC for INVEGA SUSTENNA 156 MG/ML SYRG has risen 103.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for INVEGA SUSTENNA 156 MG/ML SYRG?
Since Nov 28, 2013, the NADAC for INVEGA SUSTENNA 156 MG/ML SYRG has ranged from a low of $1146.8243 (Nov 28, 2013) to a high of $2339.6450 (May 13, 2026), with a median of $1797.6034 per ML.
Are there cheaper alternatives to INVEGA SUSTENNA 156 MG/ML SYRG?
No other NADAC-published product currently shares the active ingredient and strength of INVEGA SUSTENNA 156 MG/ML SYRG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures INVEGA SUSTENNA 156 MG/ML SYRG?
INVEGA SUSTENNA 156 MG/ML SYRG (NDC 50458056301) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.